Acrocinonide

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H29FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 67N58AU0IZ, chemically known as 9-fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acrolein but generally known as acrocinonide, which bears US NIH Compound Identifier 176868. European Medicines Agency schedules Acrocinonide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05253MIG. The term ACROCINONIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). ACROCINONIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acrocinonide under HS 29372200 and SITC 54153. As of Q4 2014, ACROCINONIDE remains the US FDA Preferred Term for this commodity. Acrocinonide bears US NLM identifiers UMLS ID C2699763 and NCI Concept Code C77405. SMILES: FC12C(C3C(C4(OC(OC4C3)C=C)C(=O)CO)(CC1O)C)CCC1=CC(=O)C=CC21C.